JAC Advance Access published online on April 13, 2007
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkm041
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Emergence of a Streptococcus pneumoniae isolate resistant to streptogramins by mutation in ribosomal protein L22 during pristinamycin therapy of pneumococcal pneumonia
1 Laboratoire de Bactériologie-Virologie-Hygiène, CHU Henri Mondor, Assistance Publique-Hôpitaux de Paris, Université Paris XII, Créteil, France 2 Service de Microbiologie, EA 2128 Relations Hôte et Microorganismes des Épithéliums, CHU Côte de Nacre, Université de Caen, 14033 Caen Cedex, France
Received 5 December 2006; returned 5 January 2007; revised 17 January 2007; accepted 29 January 2007
* Corresponding author. Tel: +33-1-49-81-68-16; Fax: +33-1-49-81-28-39; E-mail: vincent.cattoir{at}hmn.aphp.fr
Objectives: The aim of this study was to characterize the mechanism of resistance to macrolides and streptogramins of a Streptococcus pneumoniae strain isolated from blood cultures in an 80-year-old patient suffering from severe pneumonia unsuccessfully treated with pristinamycin.
Methods: Resistance genes erm(B) and mef(A) were searched for by PCR. Portions of genes for domains V and II of the 23S rRNA (rrl) and genes for ribosomal proteins L4 (rplD) and L22 (rplV) were amplified by PCR from total genomic DNA and sequenced.
Results: Resistance genes erm(B) and mef(A) were not detected. Only mutation in the rplV gene encoding ribosomal protein L22 was detected. The strain contained a six amino acid insertion (107KRTAHI108) in the C-terminus of the ribosomal protein L22.
Conclusions: This is the first report of emergence of a pneumococcus resistant to streptogramins by mutation in ribosomal protein L22 during treatment with pristinamycin.
Key Words: macrolide resistance , pneumococcus , riboprotein , rplV